𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

✍ Scribed by Wattel, E; Solary, E; Leleu, X; Dreyfus, F; Brion, A; Jouet, JP; Hoang-Ngoc, L; Maloisel, F; Guerci, A; Rochant, H


Book ID
110054180
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
105 KB
Volume
13
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment of refractory and relapsed Hod
✍ Hurd, David D. ;Haake, Robert J. ;Lasky, Larry C. ;Christiansen, Neal P. ;McGlav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

## Abstract Thirty‐three patients with recurrent or refractory Hodgkin's disease were treated with high‐dose cyclophosphamide, BCNU, and etoposide and supported with either autologous bone marrow or peripheral blood stem cells or both. Peripheral blood stem cells were comparable to bone marrow in s

Dose-intensive chemotherapy with growth
✍ Shailendra Verma; Jawaid Younus; Denise Stys-Norman; Adam E. Haynes; Martin Blac 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract A systematic review was performed to determine whether first‐line dose‐intensive chemotherapy supported by growth factor or autologous bone marrow/stem cell transplantation improves response rate, time‐to‐disease progression, or survival compared with standard‐dose chemotherapy in patie